3 unknown. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 1 | Unknown 1 |
Follow Docetaxel: new trials by email Literature Review of Docetaxel trials Research Report on Docetaxel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC Nivolumab - Carcinoma, Non-Small-Cell Lung, Docetaxel | Phase 2 | Unknown | Peking University Cancer Hospital & Institute | 72 | 2019-07-08 | 2019-07-17 |
| FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma Irinotecan, 5-FU, Leucovorin - Stomach Neoplasms, Gastrointestinal Neoplasms | Phase 2 / Phase 3 | Unknown | Blokhin's Russian Cancer Research Center | 538 | 2019-01-29 | 2021-04-13 |
| Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer anlotinib plus chemotherapy, chemotherapy - Lung Neoplasms, Docetaxel | Phase 2 | Unknown | The First People's Hospital of Lianyungang | 60 | 2018-08-01 | 2018-07-18 |
Carcinoma, Non-Small-Cell Lung (1) · Gastrointestinal Neoplasms (1) · Lung Neoplasms (1) · Stomach Neoplasms (1)
Neoplasms (3) · Neoplasms by Site (3) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Lung Neoplasms (1) · Stomach Diseases (1)
Docetaxel (2) · Drug Therapy (1) · Fluorouracil (1) · Irinotecan (1) · Leucovorin (1) · Nivolumab (1) · Oxaliplatin (1) · anlotinib (1)
Blokhin's Russian Cancer Research Center (1) · Peking University Cancer Hospital & Institute (1) · The First People's Hospital of Lianyungang (1)
China (2) · Russia (1)